Updated on 1 October 2026
HTP Antibody Production & Developability Assessment Services
Key Account Manager at Sino Biological Europe GmbH
Berlin, Germany
About
Screening hundreds or thousands of ScFvs, VHHs, or minibinders can be slow, costly, and uncertain especially when cell-based expression fails or purification delays decisions.
Our high-throughput, cell-free protein synthesis workflow generates expression and affinity data in as little as 5–8 days, with expression success rates above 99%. By screening directly from crude supernatants and using SPR for reliable binding analysis, we help reduce purification bottlenecks and identify strong candidates faster.
Additional self-association and hydrophobicity testing provides early developability insights, helping you advance the right molecules with greater confidence.
More details here.
Organisation
Similar opportunities
Expertise
Peter Bou Dib
Key Account Manager at Sino Biological Europe GmbH
Berlin, Germany
Expertise
Reduce Uncertainty in Kinase Screening
Peter Bou Dib
Key Account Manager at Sino Biological Europe GmbH
Berlin, Germany
Expertise
A well-defined marker for confident Tau research: p-Tau217
Peter Bou Dib
Key Account Manager at Sino Biological Europe GmbH
Berlin, Germany